Kantonsspital St.Gallen


Hans Rickli & Michaela Gemperle

abstract Explore Clinical Utility of Evolocumab in Combination with
an e-Health System: Swiss Prospective Observational
Study in Patients with clinical Atherosclerotic
Cardiovascular Disease (ASCVD) (ECARA)
type of project clinical studies
status completed
start of project 2017
end of project 2019
study design Describe lipid parameters in patients on Evolocumab at
baseline and over 12 months in an observational real
world setting. Maintenance of LDL-c reduction over the
study period serves as surrogate for persistence with
therapy and informs us about the utility of a bi-weekly or
monthly SC application in clinical practice
responsible person Prof. Dr. Hans Rickli